Eric Hoffman Net Worth & Insider Trades

Eric Hoffman - Chief Business Officer, Genocea Biosciences, Inc

As of June 25, 2018

What is Eric Hoffman's Net Worth?

The current estimated net worth of Genocea Biosciences, Inc's Chief Business Officer, Eric Hoffman, is estimated to be about $7.07 . Eric Hoffman owns about 11,790 units of Genocea Biosciences, Inc common stock. In the last 4 years at Genocea Biosciences, Inc, Eric Hoffman has sold an estimated value of $0 worth.

What is Eric Hoffman's Past Insider Trading?

Eric Hoffman's largest purchase order was 7,000 units , worth over $24.41K on November 9, 2016. In total, Eric Hoffman has made about 7 transactions over 4 years of their time at Genocea Biosciences, Inc. Eric Hoffman usually trades in February and March, with the busiest year in 2018 and 2016.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Eric Hoffman

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Eric Hoffman's' Mailing Address?

  • Mailing address is C/o Genocea Biosciences, Inc. 100 Acorn Park Drive, 5th Floor Cambridge MA 02140 MA

What are Genocea Biosciences, Inc's Past Insider Trades?

Genocea Biosciences, Inc's most recent insider trade came on June 3, 2022 by Diantha Duvall who sold 1,355 units worth $81.3 . In the last 8 years, insiders at Genocea Biosciences, Inc have sold an estimated value of $10.16M and bought an estimated value of $260.54M worth of shares. Insider trading is most common in June, with the busiest year in 2019. The most active traders at the company are Jessica Flechtner, Chief Scientific Officer,  William Clark, President and CEO,  and George Siber, Director .

GENOCEA BIOSCIENCES, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...